Double-stranded oligonucleotide molecules to P53 and methods of use thereof
US9932578B2 · kind B2 · utility
24Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 12, 2013 |
| Grant date | Apr 3, 2018 |
| Priority date | — |
| Expiry date | Sep 12, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application relates to nucleic acid compounds, compositions comprising same and methods of use thereof for treatment of various diseases, disorders and conditions. The compounds are preferably chemically synthesized and modified double-stranded nucleic acid molecules which down regulate expression of a p53 gene.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.